Lupin Limited has agreed to acquire all rights to a couple of inhalation medicines, namely Brovana (arformoterol tartrate) Inhalation Solution and Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, from Sunovion Pharmaceuticals for $75 million. The Indian pharma company anticipates the deal to be incremental to earnings in the first year. According to Lupin, the acquisition of […]
Lupin Limited said that it has launched the authorized generic version of Brovana (arformoterol tartrate) Inhalation Solution 15 mcg /2 mL, unit-dose vials, of Sunovion Pharmaceuticals, in the US. Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL has approval in the US for the long-term, twice-daily maintenance treatment of bronchoconstriction in patients having chronic obstructive pulmonary […]
